Medicis Pharmaceutical Corp. (MRX) Tops Q4 EPS by 15c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom forecasts quarterly sales below estimates amid rising custom AI chip competition
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Marex Group PLC (MRX) PT Raised to $42 at Jefferies
March 10, 2025 4:52 AM EDTJefferies analyst Daniel Fannon raised the price target on Marex Group PLC (NASDAQ: MRX) to $42.00 (from $38.00) while maintaining a Buy rating.
The analyst comments "Following 4Q24 results, our EPS estimate for 1Q25 remains unchanged at $0.83 and our FY25 EPS estimate increases from $3.00 to $3.11. These... More
